In the SWOG S0014 study, 3 cycles of R‐CHOP and consolidative RT provided a more favorable PFS than 3 cycles of R‐CHOP alone for patients with limited‐stage, aggressive B‐cell lymphomas.30 The gene discussed is DDIT3; the disease is B-cell non-Hodgkin lymphoma.